Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02342119 · ClinicalTrials.gov registry record · NA
Increasing Equity in Transplant Evaluation and Living Donor Kidney Transplantation
A NA study, sponsored by University of Pittsburgh.
- Completed
- Registry status
- NA
- Development phase
- 1,315
- Enrollment target
NCT02342119 is a NA study that has completed, run by University of Pittsburgh. The registered enrollment target is 1,315 participants.
The verdict
NCT02342119, a NA study, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,315 participants
- Enrollment target
Study Summary
Living donor kidney transplantation (LDKT) is the optimal treatment for end-stage kidney disease (ESKD). But, the evaluation process for a kidney transplant is lengthy, time consuming, and burdensome to the patient. Also, race disparities exist in rates of transplant evaluation completion, transplantation, and LDKT. Our previous and ongoing NIDDK-funded research indicates that cultural factors (i.e., perceived discrimination in health care, religious objection to LDKT), transplant knowledge, and demographic characteristics (e.g., age, education, income) independently and significantly predict time to complete transplant evaluation. In December 2012 the investigators' transplant center implemented a one-day streamlined evaluation process, dubbed Kidney Transplant Fast Track (KTFT), but it has not been evaluated for efficacy or cost effectiveness. Thus, the investigators propose a quasi-experiment to determine the efficacy and cost-effectiveness of the KTFT (n=1030) compared to historical controls (n=1140) who were recruited for the investigators' current NIDDK study to increase transplant rates. At the same time, the investigators will conduct a randomized controlled trial (RCT) targeting vulnerable patients with the educational component of the TALK intervention (Talking About Live Kidney Donation) to increase LDKT. For both components of the proposal, the investigators will target vulnerable populations because they are most at risk for extended evaluation times and lower rates of LDKT. Using CONSORT standards, participants will be randomly assigned to TALK (n=515) versus no-TALK (n=515) conditions and undergo two interviews at pre-transplant work-up and at completion of transplant evaluation in order to: (1) test whether KTFT and TALK will reduce transplant evaluation time, and increase rates of transplant and LDKT in members of vulnerable groups; (2) determine whether engaging in a streamlined and coordinated-care evaluation experience within the transplant cente
Interventions
- OTHER Talking About Living Kidney Donation
- OTHER Kidney Transplant Fast Track
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,315 participants |
| Start Date | 2015-05-01 |
| Est. Completion | 2020-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02342119
The ClinicalTrials.gov registry entry for NCT02342119 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,315 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Talking About Living Kidney Donation is the first listed.
NCT02342119 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02342119 about?
NCT02342119 is a clinical study titled "Increasing Equity in Transplant Evaluation and Living Donor Kidney Transplantation". Living donor kidney transplantation (LDKT) is the optimal treatment for end-stage kidney disease (ESKD). But, the evaluation process for a kidney transplant is lengthy, time consuming, and burdensome to the patient. Also, race disparities exist in rates of transplant evaluation completion, transplan...
What is the current status of trial NCT02342119?
This trial is currently completed. It is a NA study. The enrollment target is 1,315 participants. The study started on 2015-05-01. Estimated completion is 2020-08.
What interventions are being tested in trial NCT02342119?
The interventions under investigation include: Talking About Living Kidney Donation (OTHER), Kidney Transplant Fast Track (OTHER).
Who is sponsoring clinical trial NCT02342119?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.